ANIX – anixa biosciences, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ANIX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/14

10:19 pm

anix

Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference [Yahoo! Finance]

Low Report

Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference [Yahoo! Finance]

Report

4/9

09:37 am

anix

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 [Yahoo! Finance]

Low Report

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 [Yahoo! Finance]

Report

4/9

09:05 am

anix

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026

Medium Report

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026

Report

4/8

08:24 am

anix

Anixa Biosciences (ANIX) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.

Medium Report

Anixa Biosciences (ANIX) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.

Report

4/7

08:55 am

anix

Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026

Low Report

Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026

Report

4/6

09:25 am

anix

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs [TheStreet.com]

Medium Report

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs [TheStreet.com]

Report

4/6

09:22 am

anix

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs [Yahoo! Finance]

Medium Report

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs [Yahoo! Finance]

Report

4/6

09:10 am

anix

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs

Medium Report

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs

Report

4/1

09:03 am

anix

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing [TheStreet.com]

Medium Report

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing [TheStreet.com]

Report

4/1

08:50 am

anix

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing

Low Report

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing

Report

3/31

08:37 am

anix

Anixa Biosciences (ANIX) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.

Medium Report

Anixa Biosciences (ANIX) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.

Report

3/30

09:27 am

anix

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer [Yahoo! Finance]

Low Report

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer [Yahoo! Finance]

Report

3/30

09:05 am

anix

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer

Medium Report

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer

Report

3/23

01:04 am

anix

Anixa Biosciences (ANIX) was upgraded by Wall Street Zen from "sell"

Medium Report

Anixa Biosciences (ANIX) was upgraded by Wall Street Zen from "sell"

Report

3/15

01:05 am

anix

Anixa Biosciences (ANIX) was downgraded by Wall Street Zen from "hold

Medium Report

Anixa Biosciences (ANIX) was downgraded by Wall Street Zen from "hold

Report

3/13

04:53 pm

anix

Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress [Yahoo! Finance]

Medium Report

Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress [Yahoo! Finance]

Report

3/12

11:05 am

anix

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast [Yahoo! Finance]

Low Report

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast [Yahoo! Finance]

Report

3/12

10:38 am

anix

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast

Neutral Report

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast

Report

3/9

08:41 am

anix

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology [Yahoo! Finance]

Low Report

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology [Yahoo! Finance]

Report

3/9

08:30 am

anix

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology

Neutral Report

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology

Report

3/2

09:23 am

anix

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress [Yahoo! Finance]

Low Report

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress [Yahoo! Finance]

Report

3/2

09:10 am

anix

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress

Low Report

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress

Report

2/23

08:55 am

anix

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat

Medium Report

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat

Report

2/10

04:06 pm

anix

Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance [Yahoo! Finance]

Medium Report

Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance [Yahoo! Finance]

Report

2/9

08:00 am

anix

Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation

Medium Report

Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.